Hepatitis B immune globin dose requirements following orthotopic liver transplantation for chronic hepatitis B cirrhosis

Transplantation Proceedings

Volumn 28, Issue 3, 1996, Pages 1687-1688

  McGory, R ^a   Ishitani, M ^a   Oliveira, W ^a   Stevenson, W ^a   McCullough, C ^a   Pruett, T ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY;

ANTIBODY TITER; CLINICAL ARTICLE; CONFERENCE PAPER; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS B; HUMAN; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; VIRUS REACTIVATION;

DNA, VIRAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOGLOBULINS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; RECURRENCE; REOPERATION;

EID: 0029991583     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)